Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/618
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDr.Achyuth A Shivapur, BH0115001-
dc.date.accessioned2021-04-08T12:04:20Z-
dc.date.available2021-04-08T12:04:20Z-
dc.date.issued2018-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/618-
dc.description.abstractBackground The incidence of diabetes and its complications are on a steady rise. The risk of lower extremity amputations is 15 fold higher in diabetics as compared to non-diabetics. Chronic diabetic foot ulcer is the leading cause of amputations in these patients. These diabetic ulcers are known to be refractory to conventional treatment and may herald severe complications if not treated wisely. Topical Timolol acts by improving keratinocyte migration and accelerates epithelialization. Objective of the study “To compare the efficacy of topical Timolol versus normal saline dressing in the treatment of diabetic foot ulcers – a randomized controlled trial" Methodology The present study was a randomized controlled trial conducted at KLES Dr. Prabhakar Kore Hospital and MRC Belagavi. Total of 60 patients were enrolled. They were divided into two groups through computerized randomization . Control group patients were treated with conventional dressing and study group patients were treated with topical Timolol(0.5%) dressing and observed for reduction in the ulcer size over a span of 15 days. Results The study group patients showed reduction in ulcer size of about 26.71% as against 12.39 % of the control group which is statistically significant( P value at 0.0001.) Conclusion Topical Timolol dressing showed faster and better healing rates as compared to normal saline dressing . Background The incidence of diabetes and its complications are on a steady rise. The risk of lower extremity amputations is 15 fold higher in diabetics as compared to non-diabetics. Chronic diabetic foot ulcer is the leading cause of amputations in these patients. These diabetic ulcers are known to be refractory to conventional treatment and may herald severe complications if not treated wisely. Topical Timolol acts by improving keratinocyte migration and accelerates epithelialization. Objective of the study “To compare the efficacy of topical Timolol versus normal saline dressing in the treatment of diabetic foot ulcers – a randomized controlled trial" Methodology The present study was a randomized controlled trial conducted at KLES Dr. Prabhakar Kore Hospital and MRC Belagavi. Total of 60 patients were enrolled. They were divided into two groups through computerized randomization . Control group patients were treated with conventional dressing and study group patients were treated with topical Timolol(0.5%) dressing and observed for reduction in the ulcer size over a span of 15 days. Results The study group patients showed reduction in ulcer size of about 26.71% as against 12.39 % of the control group which is statistically significant( P value at 0.0001.) Conclusion Topical Timolol dressing showed faster and better healing rates as compared to normal saline dressing .en_US
dc.language.isoenen_US
dc.publisherK.L.E. Academy of Higher Education & Research, Belagavien_US
dc.subjectTopical Timolol , Diabetic foot ulcer, Diabetes mellitus. Topical Timolol , Diabetic foot ulcer, Diabetes mellitus.en_US
dc.titleTo Compare The Efficacy Of Topical Timolol Versus Normal Saline Dressing In The Treatment Of Diabetic Foot Ulcers – A Randomized Controlled Trialen_US
dc.typeDissertationsen_US
Appears in Collections:General Surgery MS

Files in This Item:
File Description SizeFormat 
Dr.Achyuth A Shivapur BH0115001.pdf2.44 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.